Formulation of oral compositions comprising arsenic trioxide and methods of use thereof
US7521071B2 · kind B2 · utility
8Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 23, 2003 |
| Grant date | Apr 21, 2009 |
| Priority date | — |
| Expiry date | May 15, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an oral formulation of arsenic trioxide (As2O3) for the treatment of a variety of hematological malignancies, including acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). The present invention also provides methods for making the oral arsenic trioxide formulation. Methods of using the oral arsenic trioxide formulation are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.